The independent additive value of total greyscale + power Doppler synovitis ... The independent additive value of total greyscale + power Doppler synovitis.

Slides:



Advertisements
Similar presentations
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Advertisements

Figure 1 Data-selection process
Figure 1 Flow diagram detailing the systematic review process.
(A) Mean (s.d.) ... (A) Mean (s.d.) baseline values for study variables for patients with and without tophi. (B) Baseline (s.d.) quality of life scores.
(A) Calcinosis cutis on the extensor side of the left upper arm ...
Figure 1 Mechanism of mortality benefit associated with radial access
(A) mSchober in DESIR; (B) mSchober in SPACE; (C) LSF ...
Figure 1 Phases of the research. Author’s own work.
(A–B) Images of US ... (A–B) Images of US assessment of both patients who developed peripheral arthritis during vedolizumab treatment undergoing US-guided.
Fig. 1 Bone scintigraphy of the right tibia of the patient at disease onset (A), after 10 years of calcitonin ... Fig. 1 Bone scintigraphy of the right.
Figure 1. Multivariable-adjusted hazard ratios (solid line) for incident chronic obstructive pulmonary disease as a ... Figure 1. Multivariable-adjusted.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.
AHA: American Heart Association; ALT: ...
Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.
Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.
Fig. 1 CT demonstrating aortic wall thickening with renal artery involvement (short arrow). There is also subtle ... Fig. 1 CT demonstrating aortic wall.
Source: Figure created by the author based on data ...
(A) Axial ... (A) Axial images showed symmetric, strong high intensity in the connective tissues surrounded by femoral muscles and mild high intensity.
bDMARD: biologic DMARD.
(A) Upper ... (A) Upper gastroduodenoscopy showing gastric antral vascular ectasia with visible bleeding. (B) Nailfold capillaroscopy showing dilated capillaries.
(A) Pelvic X-ray showing diffuse osteoaddensing ...
Black: diagnosis ... Black: diagnosis from any department; grey: diagnosis at a rheumatology department. Unless provided in the caption above, the following.
RCTs: randomized controlled ...
Point estimates with ... Point estimates with 95% CI. HR: hip replacement; KR: knee replacement. Unless provided in the caption above, the following copyright.
Fig. 1 Graphical representation of improving mortality in stroke patients since the inception of a national stroke ... “Graph courtesy of George Dunn,
Fig. 1 MRI aspect of an osteitis of the left acetabulum at baseline (A), 3 months (B), 1 year (C) and 2 years later, ... Fig. 1 MRI aspect of an osteitis.
Take home figure The protective role of CNP/NPR-B/NPRC.
Fig. 3 Interrelationship between themes describing the experiences of people with shoulder disorders Unless provided in the caption above, the following.
A. PMPs; B. endotheliocyte-derived MPs; C. leukocyte-derived MPs
x-axis, post-partum days. Closed ...
Fig. 1 HRCT of the chest, showing centrilobular nodules (white arrows in A and B), a large subpleural nodule (black ... Fig. 1 HRCT of the chest, showing.
Fig. 1. A flowchart of cohort participants screened, enrolled and followed-up between 1 July 2015 and 31 May Fig. 1. A flowchart of cohort participants.
Fig. 1 Papules in an old tattoo as the presenting sign of systemic sarcoidosis in an otherwise asymptomatic ... (A) Nodular papules in the tattoo. (B)
Fig. 1 Subacute cutaneous lupus erythematous at the lower limbs
Fig. 1 Flow chart of included patients for analyses
Rats were treated for 21 days ...
Fig. 1 Flow chart for selection of study subjects
Prevalence and distribution of ...
Figure 1 Cumulative late adjusted survival in cardiac resynchronization therapy defibrillator and pacemaker patients. ... Figure 1 Cumulative late adjusted.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Figure 1 Relationships between pair indices of dance performance (joint entropy or mutual information) and the past ... Figure 1 Relationships between.
Figure 1. Time–kill studies for selected isolates (each line represents the average of duplicate studies). AMP, ... Figure 1. Time–kill studies for selected.
Figure 1. Percentage of Pacific and European children completing all components of B4SC in 2013 and 2015 Figure 1. Percentage of Pacific and European.
Figure 1 MIC test strips showing reversion of daptomycin resistance of isolate 5 passaged in vitro. This figure ... Figure 1 MIC test strips showing reversion.
(A) Hypoechoic ‘halo sign’ of ...
Figure 1. Trunk and leg fat over study period. LS, log transformed.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Fig. 1 Kaplan-Meier plot presenting no difference in progression to RA in patients with clinically suspect ... Fig. 1 Kaplan-Meier plot presenting no difference.
Figure 1. Oncoprint of selected pathogenic alterations detected in ctDNA. Unless provided in the caption above, the following copyright applies to the.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Fig. 1 A network representation of top 100 co-occurring terms
Figure 1. Genetic context of blaNDM-21 on pNDM21_020023
Fig. 1 Statistics of the main characters’ dialogues.
Figure 1 Patient selection.
Fig. 1 Query formulation process in CLIR
The figure shows the fraction of ...
Figure 1 Grant agencies and charitable foundations supporting Plan S.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Fig. 1 Schematic subcategorization of AAV in three clinically relevant disease categories defined by clinical ... Fig. 1 Schematic subcategorization of.
Figure 3. Key words and phrases from narrative text by classification category. Unless provided in the caption above, the following copyright applies to.
Figure 1 Strategies for reconciling protection and participation.
Figure 1. Kaplan Meier curves showing crude product limit survival estimates and 95% confidence intervals for time to ... Figure 1. Kaplan Meier curves.
Figure 1 ABCDE of primary prevention.2
Figure 1. Forest plot of lung cancer mortality in LDCT trials.
Table 2. Mean noise level results for hand dryers in dBA
Figure 1. Overall response rates in wild-type versus RAS and RAS/BRAF mutations detected by nanofluidic digital PCR ... Figure 1. Overall response rates.
Figure 1. Kaplan–Meier curves showing the impact of the different pretreatment HIV-1 drug resistance categories on the ... Figure 1. Kaplan–Meier curves.
Presentation transcript:

The independent additive value of total greyscale + power Doppler synovitis ... The independent additive value of total greyscale + power Doppler synovitis load (A, B) or scan impression (C, D) is shown among the entire cohort (n = 831; A, C) and the sub-cohort of ACPA-seronegative individuals (n = 703; B, D). AUROCs (95% confidence intervals) for corresponding curves are colour-coded, and P-values denote significant differences between AUROCs (see Methods). See text for further details. AUROC: area under receiver operating characteristic curve; ROC: receiver operating characteristic. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.comThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) Rheumatology (Oxford), kez008, https://doi.org/10.1093/rheumatology/kez008 The content of this slide may be subject to copyright: please see the slide notes for details.